The abstract is read at the publisher; the summary is JClub's.
In 2023, global malignant bone cancer burden included 111 000 cases, 76 600 deaths, and 3.02 million DALYs, with age-specific peaks and regional ASR disparities.
- Why it matters: Bone cancer survival varies by age and location, yet policymakers need consistent global estimates and forward-looking trends to plan resources and address geographic inequities.
- What they did: Using GBD 2023 standardized methods, the study estimated incidence, mortality, and DALYs for all ages across 204 countries and territories from 1990–2023, then forecasted through 2050, reporting 95% uncertainty intervals and age-standardized rates.
- The result: From 1990 to 2023, cases, deaths, and DALYs rose globally while mortality and DALY ASRs stayed relatively stable; forecasts suggest potential increases in cases and deaths by 2050.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.